Patent · US Active

Compounds

US9023855B2 · kind B2 · utility

2Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2014
Grant dateMay 5, 2015
Priority date—
Expiry dateFeb 11, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P17/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I):are useful as inhibitors of human neutrophil elastase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.